Immunology CDMOs

Padagis LLC

United States

Padagis LLC is a U.S.-based generic pharmaceutical company specializing in development and manufacturing of extended topical and specialty pharmaceutical products. Product portfolio includes prescription creams, ointments, gels, foams, sprays, patches, nasal treatments, and suppositories, with a focus on Paragraph IV generic products. Also manufactures naloxone nasal spray (awarded New York State Department of Health contract in 2025). Over 1,300 employees. Offers contract manufacturing, licensing, and joint venture partnerships.

Pfizer CentreOne

Belgium

Pfizer CentreOne is a global CDMO embedded within Pfizer, specializing in commercial manufacturing of oral solid doses, sterile injectables, biologics including monoclonal antibodies, and antibody-drug conjugates. It leverages Pfizer's global manufacturing network across six continents with cGMP-compliant sites and over 170 years of pharmaceutical manufacturing expertise, backed by $1B+ annual manufacturing investments.

Pharmaron

China

Pharmaron is a premier life science CRO/CDMO providing comprehensive R&D and manufacturing services across the entire drug discovery to commercialization process. The company serves small molecules, biologics, ADCs, cell & gene therapies, and protein degraders. It offers laboratory services, chemistry/manufacturing/controls (CMC), clinical development, and biologics/CGT manufacturing. Pharmaron acquired a commercial API manufacturing facility in the UK and operates a gene therapy CDMO in Liverpool with a 20-year track record. The company has over 20 years of experience across 7+ facilities in the UK, US, and China.

Pharmascience

Canada

Pharmascience is Canada's largest privately-owned pharmaceutical company, a leading manufacturer of generic, branded, and over-the-counter pharmaceuticals. The company has recently expanded its CDMO services with a new commercial business unit, investing over $120 million to expand its sterile injectable manufacturing facility in Candiac, Quebec, aiming to more than triple capacity. Pharmascience's ambition is to become a world leader in the sterile injectable CDMO segment. The company distributes products in over 50 countries and invests approximately $65 million per year in R&D in Canada. The Pendopharm division offers specialty medicines in gastroenterology, orthopedics, and neurology.

Pharma Tech Industries

United States

Pharma Tech Industries (PTI) is a pharmaceutical CDMO specializing exclusively in non-sterile dry powder blending and high-speed packaging. Founded in 1972, the company operates multiple FDA-registered, NSF-compliant, climate-controlled facilities in Georgia and Missouri under strict cGMP standards. PTI provides development to high-volume commercial-scale production for pharmaceutical, OTC drug & personal care, and nutritional health & medical foods. Delivery formats include sachets, stick packs, bottles, pouches, effervescents, tablets, capsules, drug-devices, and medical swabs. The company has onsite GMP analytical/microbiology labs and uses quality systems including Empower, eQMS, EDMS, and ERP Serialization. PTI earned the highest possible score in the 2024 CDP SME environmental evaluation.

ProBioGen AG

Germany

ProBioGen AG is a fully integrated CDMO headquartered in Berlin, Germany, specializing in the development and GMP manufacturing of biopharmaceuticals, viral vectors, and vaccines. The company offers cell line development, process development, GMP manufacturing up to 1000L bioreactors, and comprehensive analytical services. ProBioGen leverages proprietary technologies including GlymaxX (ADCC enhancement), DirectedLuck (transposase system), and CHO.RiGHT production systems.

Rentschler Biopharma

Germany

Rentschler Biopharma is a leading global CDMO focused exclusively on biopharmaceuticals, with over 50 years of industry experience. The company contributed to nearly 25% of FDA-approved biopharmaceuticals in 2023, has supported 180+ biotherapeutics, and serves 180+ clients worldwide. It is an independent family-owned company employing approximately 1,400 people.

ScinoPharm (scinopharm.com)

China

ScinoPharm Taiwan is a CDMO headquartered in Tainan Science Park, Taiwan, specializing in high-tech oncology APIs, peptide synthesis, and sterile injectable drug products. With FDA-approved facilities and 18 flexible manufacturing lines, ScinoPharm provides end-to-end services from API development through sterile injectable fill/finish, with a strong focus on complex generics and oncology therapeutics.

Sofgen Pharmaceuticals

United States

Sofgen Pharmaceuticals, part of Procaps Group, is an integrated softgel CDMO that offers end-to-end solutions in softgel technologies from development through delivery. The company serves pharmaceutical, OTC, and nutraceutical customers, with operations across 13 countries in the Americas and customers in 50+ countries.

Tanvex Biopharma USA, Inc

Taiwan

Tanvex BioPharma USA is a vertically-integrated biopharmaceutical company that has launched a CDMO division (Tanvex CDMO) offering pre-clinical through commercial-scale contract manufacturing of microbial and mammalian-derived biotherapeutics. Founded by Dr. Allen Chao (former founder/CEO of Watson Pharmaceuticals). They received FDA approval for Nypozi (biosimilar filgrastim) and have an FDA-accepted biosimilar BLA. The CDMO offers end-to-end biologics manufacturing services. Their San Diego facility is FDA-registered with 1 approved product (injectable). They have capabilities in both biosimilar development and contract manufacturing for third parties.

TAPI (Teva API)

Netherlands

TAPI (Teva Active Pharmaceutical Ingredients) is the API division of Teva Pharmaceutical Industries, positioned as the world's leading international supplier of APIs with 350+ products in their portfolio. They offer integrated API and CDMO services, leveraging 85+ years of API development and manufacturing expertise. TAPI provides customized solutions including complex API development, peptide manufacturing (including GLP-1 capability), and end-to-end manufacturing. They have a partnership with Antheia for biosynthetic pharmaceutical ingredients and with Sagimet Biosciences for resmetirom API. TAPI operates globally with multiple manufacturing sites.

ten23 health

Switzerland

Swiss CDMO specializing in formulation, analytical and process development, sterile manufacturing (fill and finish), and testing of injectable medicines. First CDMO in the pharmaceutical industry for injectables to be B Corp certified. Operates from Basel and Visp, Switzerland. Opened new VIVA2 facility with expanded sterile manufacturing lines. QC laboratories approved by both Swissmedic/RHI and FDA. Partners with BD on Libertas wearable injector commercialization. Supports biologics, small molecules, and RNA therapeutics.

Thermo Fisher Scientific Inc.

China

One of the world's largest pharmaceutical CDMOs through its Patheon pharma services division. Provides end-to-end pharmaceutical development and manufacturing services for both small molecules and biologics, from API manufacturing through drug product, sterile fill/finish, packaging, and commercial supply. Operates 31+ FDA-registered facilities globally. 158 FDA inspections on record (52 NAI, 104 VAI, 2 OAI). Also provides cell therapy manufacturing solutions (CTS Rotea cell processing system), laboratory informatics, bioprocessing equipment, and reagents. 4 FDA-approved drug products. Revenue >$40B (full company).

UI Pharmaceuticals

United States

UI Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States, operated by the University of Iowa. They offer comprehensive drug product CDMO services from formulation development through commercialization. In 2023, they launched a new 16,000 sq ft sterile processing facility with fill lines. They serve pharmaceutical, biotech, pediatrics, oncology, and research organizations worldwide.

Wheeler Bio

United States

Wheeler Bio is a biologics CDMO based in Oklahoma City, specializing in accelerating antibody-based therapeutics from discovery to cGMP clinical supply. The company uses its proprietary Modular CMC approach to reduce risk and accelerate timelines for drug developers. Wheeler Bio offers cell line development, process development, analytics, and manufacturing services for monoclonal antibodies, bispecific antibodies, and fusion proteins.

WuXi Biologics

China

WuXi Biologics is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) for biologics, with over 12,000 employees across the US, Ireland, Germany, China, and Singapore. The company provides end-to-end solutions from discovery through commercial manufacturing for biologics including monoclonal antibodies, bispecifics, ADCs, vaccines, and mRNA products using both mammalian and microbial expression systems.

Zydus Lifesciences Ltd

India

Zydus Lifesciences Ltd. (formerly Cadila Healthcare) is a major Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, ranked 4th in the Indian pharma industry with 29,000+ employees globally. In June 2025, Zydus entered the global biologics CDMO business by acquiring Agenus Inc.'s U.S. manufacturing facilities in Emeryville and Berkeley, California for $75M upfront (plus $50M milestones), now operating as independent subsidiary Zylidac Bio LLC. These facilities provide end-to-end biologics development and manufacturing from pre-clinical to commercial stages, including monoclonal antibody manufacturing for Phase-3 immuno-oncology products (Botensilimab and Balstilimab). Zydus has 15 FDA-registered facilities, 156 FDA-approved products across capsules, tablets, creams, gels, injectables (including liposomal), ointments, suppositories, and transdermal patches. They have 58 FDA inspections (25 NAI, 28 VAI, 5 OAI) and 51 recalls (2 Class I, 40 Class II, 9 Class III). Manufacturing sites span Gujarat, Maharashtra, Goa, Himachal Pradesh, Sikkim (India), plus US (Vermont, Pennsylvania, Missouri) and Brazil. Their CDMO services are specifically the biologics arm through Zylidac Bio -- the broader Zydus business is primarily own-brand generic pharmaceuticals.

ACON Pharmaceuticals

United States

ACON Pharmaceuticals Inc is a specialty contract research organization (CRO) based in Cranbury, New Jersey, focused on drug product development. They specialize in drug delivery systems including siRNA, mRNA, liposomes, nanocrystals, and complex generics development via the 505(b)(2) pathway. They are primarily a development-focused CRO, not a manufacturing organization.

Akron Biotech

United States

Akron Biotech is a leading contract manufacturing organization (CMO/CDMO) providing cGMP-compliant solutions for cell and gene therapy. The company manufactures cytokines, growth factors, media, buffers, and transfection/transduction reagents, and recently expanded to a second 60,000 sq ft biologics manufacturing facility in Sarasota, Florida, to support growing demand for ancillary materials in cell and gene therapy.

Avanti Polar Lipids (Croda Pharma)

United States

Avanti Polar Lipids, now a Croda Pharma brand (Avanti Research), is a US-based manufacturer and CDMO specializing in high-purity lipids for pharmaceutical and diagnostic applications. Through Croda Alabaster, their FDA-inspected cGMP manufacturing division, they provide contract manufacturing of lipid APIs, excipients, and adjuvants for vaccines and immunotherapies. Services span from custom lipid synthesis at 25mg scale through clinical trial materials to commercial-scale bulk production (1L to 55L batches), including liposome and nanoparticle formulation in cGMP manufacturing suites. They offer lipid-based drug delivery system development, method development and validation, ICH-compliant stability testing, and full regulatory support for IND/NDA submissions.

Cellab CDMO

Andorra

Cellab CDMO is a Contract Development and Manufacturing Organization based in Andorra, specializing in Advanced Therapy Medicinal Products (ATMPs) including cell and gene therapies. The company provides end-to-end services from concept and early-stage development through clinical programs and commercialization under GMP. Cellab supports therapy developers with an agile approach to accelerate ATMP development from bench to bedside.

CellEasy

France

Cell-Easy (CellEasy) is a French CDMO specializing in GMP cell therapy manufacturing, supporting academic laboratories, biotechs, and pharma companies through development and clinical programs. The company has manufactured over 1,000 clinical doses in its GMP facility and has handled 15+ cell types including T cells, NK cells, T regs, MSCs, iPSCs, and immortalized cell lines across 50+ development programs. Cell-Easy follows ICH Q2(R1), European Pharmacopoeia, EMA/MHRA, and US Pharmacopoeia standards.

Cellex Cell Professionals GmbH

Germany

Cellex Cell Professionals GmbH is a European CDMO with over 10 years of experience in autologous and allogeneic cell therapy, partnering with top pharma companies, biotech firms, and academic institutions for clinical trials and post-approval commercial production. Three approved CAR-T therapies are produced in Cellex's GMP-compliant facilities. The company provides full-service capabilities including cell collection, manufacturing of ATMPs/CGT products, process development and validation, supply chain management, GMP audits of medical facilities, and consulting from preclinical development to commercialization.

CELLforCURE by SEQENS

France

CELLforCURE by SEQENS is a leading EMA-authorized CDMO dedicated to the development and commercial manufacturing of cell and gene therapies (ATMPs). Located near Paris, the company operates a 10,000 m2 site with 3,000 m2 of GMP area featuring 7 independent GMP manufacturing lines, 48 cleanrooms, and an 800 m2 dedicated QC lab. With over 15 years of track record, CELLforCURE has completed 25+ tech transfers, manufactured 600+ autologous CAR-T commercial doses and 10,000+ allogeneic CAR-T clinical vials.

Cellistic

Belgium

Cellistic is a Belgium-based CDMO specializing in iPSC-based cell therapy manufacturing, positioned as a global leader in allogeneic iPSC-derived cell therapy production. The company offers full-spectrum manufacturing services including cell line development, process development, GMP manufacturing platforms, ready-to-use iPSC lines, and proprietary gene-editing capabilities. Cellistic operates Europe's first facility dedicated exclusively to iPSC-based cell therapy development and manufacturing in Mont-Saint-Guibert, Belgium.

Celonic

Germany

Celonic is a Swiss-based 'Pure Play' biologics CDMO offering end-to-end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics, and other complex molecules. The company is a pioneer in next-generation bioprocessing technologies including process intensification and full perfusion. Celonic operates facilities in Basel, Switzerland and Heidelberg, Germany, and has a strategic alliance with CARBOGEN AMCIS for integrated ADC development and manufacturing.

ChemPartner

China

ChemPartner is a science-based, technology-driven global CRO and CDMO with over 20 years of experience and 2,000+ scientists. The company provides end-to-end drug discovery through IND services for small molecules and biologics, including antibody discovery, ADC development, and cGMP biologics manufacturing. ChemPartner has expanded its biologics CDMO capabilities with a 67,000 sqm facility in Qidong, China and a new R&D center in Boston.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)

Taiwan

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), founded in 1964 and operating as Cenra API Solutions, is one of the largest API manufacturers in Taiwan. The company provides cGMP toll manufacturing and contract research services with FDA/EU-approved facilities, producing APIs across antifungal, immunosuppressant, oncology, cardiovascular, and peptide drug categories.

Creative Biolabs

United States

Creative Biolabs is a US-based ISO 9001:2015 certified CDMO providing comprehensive biotechnology and pharmaceutical services including antibody discovery, viral vector CDMO solutions, CAR-T cell therapy manufacturing, and custom bio-manufacturing. The company offers end-to-end services from discovery through cGMP production for biologics including AAV, lentivirus, adenovirus, and HSV vectors.

Enzene Biosciences Limited

India

Enzene Biosciences is an Indian CDMO and subsidiary of Alkem Laboratories, specializing in biologics and biosimilar development and manufacturing. The company's patented EnzeneX continuous bioprocess manufacturing platform significantly reduces the cost of producing complex biologics and monoclonal antibodies, with facilities in Pune, India and an expanding site in Hopewell, New Jersey, USA.

Fisher BioServices (Thermo Fisher)

Netherlands

Fisher BioServices is part of Thermo Fisher Scientific's Patheon pharma services division, one of the world's largest CDMOs offering end-to-end 360-degree CDMO and CRO solutions. The Patheon platform covers drug substance and drug product manufacturing for small molecules, large molecules, and advanced therapies, along with clinical supply and commercialization services.

Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Germany

The Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Leipzig is a contract research and GMP manufacturing institute specializing in cell and gene therapy, vaccines, and biologics. The institute provides GMP-compliant manufacturing of clinical trial materials (ATMPs and biologicals), process development for pharmaceutical manufacturing, and regulatory support for manufacturing authorizations and approvals.

GC Cell

South Korea

GC Cell is a South Korean cell therapy pioneer and CDMO, an affiliate of GC Biopharma. The company has its own commercialized cell therapy product (Immuncell-LC) and offers comprehensive CDMO capabilities spanning R&D, GMP manufacturing, logistics, and advanced therapies. GC Cell has expanded its CDMO footprint to the US through the acquisition of Made Scientific and a partnership with BioCentriq for cell therapy manufacturing.

GenScript ProBio

China

GenScript ProBio is a leading biologics CDMO and subsidiary of GenScript Biotech Corporation, providing end-to-end services from discovery to commercialization. The company has raised $224 million in C-round funding, operates GMP plasmid and viral vector manufacturing facilities in Hopewell, New Jersey and Nanjing, China, and has established a manufacturing facility in Singapore. GenScript ProBio specializes in antibody discovery, cell and gene therapy manufacturing, and biologics development.

Grand River Aseptic Manufacturing (GRAM)

United States

Grand River Aseptic Manufacturing (GRAM) is a premier US-based CDMO specializing exclusively in sterile injectable fill-and-finish services for liquid and lyophilized vials, pre-filled syringes, and cartridges. The company serves pharmaceutical and biotech clients with capabilities spanning clinical through commercial-scale production for biologics, small molecules, and vaccines. GRAM also partners with drug delivery device innovators to offer solutions for autoinjectors and on-body delivery systems.

Helvetic BioPharma SA

Switzerland

Helvetic BioPharma SA is a Swiss biopharmaceutical company based in Mezzovico, Ticino, specialized in the manufacturing of biological high-value products and active compounds. The company offers CMO bioprocessing services including mammalian cell culture and microbial fermentation. Its product portfolio includes recombinant proteins, hormones, and peptides, with PEGylation capabilities for long-acting molecules.

Icosagen

Estonia

Icosagen is a private, science-driven biologics CRDMO headquartered in Estonia, combining CRO and CDMO capabilities under one roof. With 25 years of expertise, the company provides integrated services spanning antibody discovery, protein production, cell line development, ADC conjugation, process development, and GMP manufacturing for mammalian protein drug candidates.

Made Scientific

United States

Made Scientific is a US-based cell therapy CDMO specializing in development and GMP manufacturing of cell-based therapies including T cells, NK cells, HSCs, MSCs, iPSCs, and TILs. The company provides services from pre-clinical support through Phase I-III clinical trials and commercial enablement, including process and analytical development, GMP cell banking, drug product manufacture, aseptic fill and finish, and QC lot release and stability testing. FDA-registered with FEI number and operations including API manufacture, analysis, labeling, manufacturing, and packaging.

Miltenyi Bioindustries (Miltenyi Biotec)

Germany

Miltenyi Bioindustries (part of the Miltenyi Biotec group) is a German CDMO specializing in cell and gene therapy manufacturing. The company offers comprehensive CGT services including cell therapy process development, cell and gene therapy manufacturing, lentiviral vector production, and manufacturing technology platforms. Miltenyi has pioneered partnerships in cell and gene therapies for over 30 years and operates a global manufacturing network. The company has 2 FDA inspections on record and has conducted clinical trials in immunology and oncology.

OmniaBio Inc

Canada

OmniaBio Inc is Canada's largest cell and gene therapy CDMO, established by CCRM in 2022. The company provides end-to-end contract development and manufacturing services for autologous and allogeneic cell therapies, lentiviral vectors, and immunotherapies. Its Hamilton, Ontario facility integrates AI, automation, and robotics to enhance manufacturing efficiency and reduce costs.

Protheragen-ING

China

Protheragen-ING is a China-based comprehensive integrated service provider specializing in drug development and biotechnology solutions. The company offers both small molecule and large molecule (antibody, ADC, protein therapy) development and manufacturing services, with an extensive pipeline of available drug development projects spanning antibody therapies, oncolytic virotherapy, cell therapy (CAR-T), and small molecules. Protheragen is FDA-registered for API manufacture and operates project incubation and equity investment services for drug candidates.

RiboPro B.V.

Netherlands

RiboPro B.V. is a Netherlands-based mRNA CDMO providing GMP-grade mRNA manufacturing, LNP (lipid nanoparticle) formulation services, and contract research. The company has over a decade of mRNA-specific experience and offers proprietary technologies including RiboStealth sequence optimization and RiboFlux GMP manufacturing platform. RiboPro serves customers ranging from early discovery through commercial production of mRNA therapeutics and vaccines.

Sandoz

Austria

Sandoz is a global leader in generic and biosimilar medicines, spun off from Novartis in 2023 as a standalone company. It manufactures and markets generic pharmaceuticals and biosimilars but operates as a branded pharmaceutical company, not a contract manufacturer for third parties.

Scinai Immunotherapeutics

Israel

Scinai Immunotherapeutics is a NASDAQ-listed biopharmaceutical company that provides boutique biologics CDMO services through its Scinai Bioservices business unit, alongside its own I&I therapeutics pipeline. The CDMO offers end-to-end drug development and manufacturing from molecule selection through Phase 3 manufacturing, with over 20 years of experience in recombinant protein development. Scinai acquired a manufacturing site in Yavne, Israel from Recipharm and established a US subsidiary (Scinai Bioservices Inc.).

Scorpius BioManufacturing

United States

Scorpius BioManufacturing is a US-based biologics CDMO focused on mammalian, microbial, and cell therapy manufacturing. The company provides cGMP manufacturing, bioanalytical, and process development services from its San Antonio, Texas facility. Note: Tivic Health acquired manufacturing assets from Scorpius, and the company has undergone corporate restructuring under Scorpius Holdings / NightHawk Biosciences.

SCTbio

Czechia

SCTbio is a Czech CDMO specializing in cell and gene therapy (ATMP) manufacturing, spun out from SOTIO. The company provides cGMP production of cell-based therapies and retroviral/lentiviral vectors from its 2,000 sqm facility in Prague, Czech Republic. SCTbio has specialized expertise in dendritic cell therapeutics, CAR-T, and viral vector production, supported by a global network of 150 apheresis collection centers.

SEQENS

Canada

SEQENS is a global integrated CDMO and specialty ingredients leader with 15 production sites across 9 countries and 5 R&D centers. The company manufactures custom and generic APIs, intermediates, excipients, custom lipids for drug delivery (mRNA/siRNA, LNP), HPAPIs, and specialty chemicals. SEQENS also operates CELLforCURE, an EMA-authorized CDMO for Advanced Therapy Medicinal Products (ATMPs/Cell & Gene Therapy). The company serves 1,500+ customers in 80+ countries with approximately 2,700 employees and ~1B EUR revenue.

Softgel Healthcare Pvt Ltd

India

Softgel Healthcare Pvt Ltd is an Indian CDMO with over 18 years of expertise in formulating, developing, and manufacturing soft gelatin capsules. Operating USFDA and EU-GMP approved facilities, the company serves over 100 partners in 60+ countries. Key products include Enzalutamide, Cyclosporine, Tafamidis, Nintedanib, and other complex softgel formulations. The company was acquired by Everstone Capital.